The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The study is to evaluate the effect of Mycophenolate Mofetil compared with losartan alone on
time to doubling of serum creatinine or the onset of end stage renal disease in patients with
advanced IgA nephropathy who are treated with the maximal tolerated daily dose of
losartan.The study will also assess the effects of MMF compared with losartan alone on the
changes of urine albumin excretion and the changes in estimated glomerular filtration rate.